Immunomet Therapeutics, Inc., 2026-02-05
An SEC Form D private-offering notice from Houston, TX, a $10,000,000 filer-stated offering target in Biotech. Filed 2026-02-05. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage biotech in Houston, TX developing oxidative phosphorylation inhibitor drugs for cancer and fibrosis.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Gyde Inc., 2026-02-11, $50M, Austin, TX
- NEONC TECHNOLOGIES HOLDINGS, INC., 2026-02-09, $36M, Calabasas, CA
- Virdee, Inc., 2026-02-09, $17.3M, Austin, TX
- XDemics Corp, 2026-02-06, $7.4M, San Rafael, CA
- Ad Hoc Coordination, LLC, 2026-02-06, $500K, Dallas, TX
- ARTELO BIOSCIENCES, INC., 2026-02-06, $50.5M, Solana Beach, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.